Last Updated: August 3, 2026

Litigation Details for Pavemetrics Systems, Inc. v. Tetra Tech, Inc. (C.D. Cal. 2021)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Pavemetrics Systems, Inc. v. Tetra Tech, Inc.

Litigation summary and analysis for: Pavemetrics Systems, Inc. v. Tetra Tech, Inc. (C.D. Cal. 2021)

Last updated: June 28, 2026

Pavemetrics Systems, Inc. v. Tetra Tech, Inc. (2:21-cv-01289) Litigation Summary and IP Risk Analysis

Executive summary: The case “Pavemetrics Systems, Inc. v. Tetra Tech, Inc.” is docketed as 2:21-cv-01289. A litigation summary and patent/IP risk analysis requires the operative filings and orders that define the asserted claims, parties’ roles (including subsidiaries and relevant affiliates), the asserted IP (if any), the relief sought, and the case posture. Those case-specific details are not present in the information provided.

What claims are asserted in Pavemetrics Systems, Inc. v. Tetra Tech, Inc. 2:21-cv-01289?

A litigation summary cannot be completed without identifying the complaint’s causes of action (e.g., patent infringement, trade secret misappropriation, copyright, breach of contract, unjust enrichment), the asserted IP assets (patent numbers, registered works, trade-secret categories), and the claim construction or legal theories actually litigated.

What is the asserted IP basis (patents, trade secrets, copyright)

A complete answer requires the asserted IP identifiers and claim scope. Without docket text for the complaint and amended pleadings, the IP basis cannot be stated.

What relief does Pavemetrics seek

Relief could include injunctive relief, damages, attorneys’ fees, disgorgement, or declaratory judgments. That relief is not stated in the provided inputs.

What is the procedural posture for Pavemetrics Systems, Inc. v. Tetra Tech, Inc. 2:21-cv-01289?

A posture analysis depends on the presence of docket entries such as: motions to dismiss, preliminary injunction motions, claim construction orders (if patent), summary judgment decisions, trial scheduling orders, and final judgment or settlement filings.

Has there been a motion to dismiss or summary judgment

No procedural outcomes are available in the provided information.

Are there any injunctions or protective orders

Trade secret cases often include protective orders and seizure or TRO-related filings. Patent cases may include preliminary injunction and bond orders. None of these docket specifics are available here.

When was the case filed and what are the key dates in 2:21-cv-01289?

A credible timeline requires at minimum: filing date, service/appearance dates, amended complaint dates, motion filing deadlines, hearing dates, and dispositive order dates.

Case timeline (needed)

No dates are provided beyond the case number.

What stage is the case in now

No status information is provided.

What patents or patent families are involved in Pavemetrics Systems, Inc. v. Tetra Tech, Inc. 2:21-cv-01289?

Patent-focused analysis requires: patent publication/application numbers, assignees, priority dates, claim numbers, and infringement allegations mapped to accused features.

Which claims are alleged to be infringed

Not available.

Are there Paragraph IV or Hatch-Waxman issues

This case caption does not establish a Hatch-Waxman posture; only docket records could confirm.

How strong is Pavemetrics’ patent estate or trade secret position in 2:21-cv-01289?

Strength assessment requires:

  • asserted claim coverage and proximity to prior art
  • standard of proof and evidence (in patent: infringement and validity defenses)
  • for trade secrets: existence of trade secret, reasonable measures, and misappropriation proof
  • any preliminary injunction findings No evidentiary record or legal rulings are available.

Invalidity, non-infringement, and defenses

Not available.

Discovery disputes and expert reports

Not available.

What products or services are accused in Pavemetrics v. Tetra Tech?

Accusation mapping requires:

  • the accused Tetra Tech systems/engagements/deliverables
  • the relevant contract scope, if any
  • technology descriptions tied to asserted claims No such facts are available.

What settlement or dismissal outcomes exist for 2:21-cv-01289?

Settlement or dismissal terms and whether dismissal is with or without prejudice are not provided.

Were there consent judgments or stipulated dismissals

Not available.

Was the case consolidated or appealed

Not available.

How does the case affect freedom to operate for Tetra Tech and customers?

Freedom-to-operate risk depends on:

  • whether there is an injunction or final judgment
  • the scope of the claims and accused systems
  • licensing or workaround pathways None of these are available.

Key Takeaways

  • The case number 2:21-cv-01289 is identified, but a litigation summary and IP risk analysis cannot be generated without the docket content and case-specific filings that specify the asserted claims, procedural posture, and outcomes.
  • No operative allegations (patents/trade secrets/contracts) or judicial orders are included in the provided information.

FAQs

  1. What causes of action does Pavemetrics assert against Tetra Tech in 2:21-cv-01289?
  2. Were any patents asserted in Pavemetrics Systems, Inc. v. Tetra Tech, Inc. (2:21-cv-01289)?
  3. Did the court issue any injunctions, TROs, or protective orders in 2:21-cv-01289?
  4. What is the current status of Pavemetrics v. Tetra Tech (2:21-cv-01289)?
  5. Did the parties reach a settlement or is the case still pending in 2:21-cv-01289?

References

  1. No sources were provided with the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.